Learn More About EXELIRIS
An emerging innovative pharmaceutical company, founded in 2023. The company focuses on high-value target discovery and drug development to address pain and protect health.
We aim at the forefront of international science and strategic needs, refining key breakthrough directions and organizing collaborative innovation among domestic and international drug research forces. We advance the development of foundational theories and breakthrough transformative technologies. Our goal is to establish a core technology system that supports development and to build a global hub for biopharmaceutical research and development.